Close Menu
InfoQuest Network
  • News
  • World
    • United States
    • Canada
    • Europe
    • Asia
    • Latin America
    • Australia
    • Africa
  • Politics
  • Business
    • Personal Finance
    • Finance
    • Markets
    • Startup
    • Investing
    • Innovation
    • Billionaires
    • Crypto
  • Tech
  • Lifestyle
  • Sports
  • Travel
  • More
    • Science
    • Entertainment
    • Health & Wellness
    • Immigration
Trending

This No-Subscription Smart Ring Inspired Me to Transform My Unhealthy Habits

July 7, 2025

Are ‘Coal-Free’ Countries Truly Clean? New Data Reveals Actual Consumption Trends

July 7, 2025

How to Stay Safe While Visiting Greece and Türkiye During the Summer Wildfire Season

July 7, 2025
Facebook X (Twitter) Instagram
Smiley face Weather     Live Markets
  • Newsletter
  • Advertise
Facebook X (Twitter) Instagram YouTube
InfoQuest Network
  • News
  • World
    • United States
    • Canada
    • Europe
    • Asia
    • Latin America
    • Australia
    • Africa
  • Politics
  • Business
    • Personal Finance
    • Finance
    • Markets
    • Startup
    • Investing
    • Innovation
    • Billionaires
    • Crypto
  • Tech
  • Lifestyle
  • Sports
  • Travel
  • More
    • Science
    • Entertainment
    • Health & Wellness
    • Immigration
InfoQuest Network
  • News
  • World
  • Politics
  • Business
  • Finance
  • Entertainment
  • Health & Wellness
  • Lifestyle
  • Technology
  • Travel
  • Sports
  • Personal Finance
  • Billionaires
  • Crypto
  • Innovation
  • Investing
  • Markets
  • Startup
  • Immigration
  • Science
Home»Health & Wellness»Is stem-cell therapy an effective treatment for type 1 diabetes?
Health & Wellness

Is stem-cell therapy an effective treatment for type 1 diabetes?

News RoomBy News RoomOctober 4, 20240 ViewsNo Comments3 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email Reddit Telegram WhatsApp

A woman with type 1 diabetes underwent stem-cell therapy using cells from her own body, resulting in her no longer needing insulin injections 75 days after the procedure. Researchers discovered that the stem-cell derived islet cells had successfully engrafted in her abdomen. Additional patients have been enrolled in the trial in China, with the goal of conducting long-term follow-up studies over the next two years. Other stem-cell based therapies for both type 1 and type 2 diabetes are also being developed and tested globally.

The breakthrough case study involved taking fat cells from a 25-year-old woman with type 1 diabetes and converting them into pluripotent stem cells. These cells were then used to create islet cells, responsible for producing insulin in the pancreas. The patient had previously undergone multiple transplants due to complications from her diabetes. The induced islet cells were injected into her abdomen and successfully engrafted, leading to reduced reliance on insulin injections and improved glucose control over time.

The woman in the case study showed significant improvement in her ability to reach target glycemic levels post-treatment, with a notable increase in insulin production and lowered long-term glucose levels. While this is the first reported case of sustained insulin production from stem-cell therapy, other trials are underway to develop similar treatments for both type 1 and type 2 diabetes. Pharmaceutical companies and research institutions are actively exploring the use of stem-cell derived islet cells to help manage and potentially reverse diabetes.

Kangen Water

Results from a phase 1/2 clinical trial on stem-cell derived type 1 diabetes treatments were presented in 2024, showcasing promising outcomes in 37 participants. Previous safety data from a trial in Canada also demonstrated the feasibility of using stem-cell derived pancreatic endoderm cells in treating diabetes. Experts in the field, including James Shapiro from the University of Alberta, expressed optimism about the potential of stem-cell therapies for diabetes but also highlighted the need for further research to address challenges such as immune response modulation and cost-effective manufacturing processes.

The success of the stem-cell therapy in the case study represents a significant milestone in diabetes research, offering hope for patients with both type 1 and type 2 diabetes. By using a patient’s own cells to create insulin-producing islet cells, the risk of rejection is minimized and the need for anti-rejection medications reduced. Ongoing studies will focus on expanding and accelerating treatment options, ensuring safety and effectiveness for a broader population of diabetic patients. Research efforts continue to refine stem-cell therapies for diabetes, with a focus on overcoming remaining challenges in immunomodulation and cost-effective production methods.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related News

Steven Alderson Makes History as First Golfer with Autism to Win G4D Tour Event

October 17, 2024

Cause of Death for Liam Payne Uncovered in Autopsy Report

October 17, 2024

Ananda Lewis of MTV Shares Her Experience with Breast Cancer Diagnosis and Treatment

October 17, 2024

Practicing mindfulness could be just as beneficial as taking an antidepressant

October 17, 2024

The impact of caffeine on disease risk: A closer look

October 17, 2024

Serena Williams discloses removal of grapefruit-sized cyst from her neck

October 16, 2024
Add A Comment
Leave A Reply Cancel Reply

Top News

Are ‘Coal-Free’ Countries Truly Clean? New Data Reveals Actual Consumption Trends

July 7, 2025

How to Stay Safe While Visiting Greece and Türkiye During the Summer Wildfire Season

July 7, 2025

The Triple Zero Call Presented to Jurors

July 7, 2025

Subscribe to Updates

Get the latest news and updates directly to your inbox.

Advertisement
Kangen Water
InfoQuest Network
Facebook X (Twitter) Instagram YouTube
  • Home
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 Info Quest Network. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.